New challenges in tuberculosis;Nuevos desafíos en tuberculosis

Revista Chilena de Enfermedades Respiratorias

Volumn 27, Issue 2, 2011, Pages 161-168

  Victorino Farga, C ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Challenges; Diagnosis; IGRA's; Multi drug resistant tuberculosis; New drugs; New vaccines; Present situation; Treatment; Tuberculosis; Tuberculosis AIDS

Indexed keywords

EID: 84860402797     PISSN: 07175698     EISSN: 07177348     Source Type: Journal    
DOI: 10.4067/s0717-73482011000200014     Document Type: Article

References (11)

1. GARCÍA C. Tuberculosis en grupos de riesgo en la Región Metropolitana. 2008. Rev Chil Enf Respir 2011; 26: 105-11.
2. FARGA V, CAMINERO J A. Tuberculosis. Tercera Edición. Editorial Mediterráneo. 2010.
3. ZÚÑIGA M. La eliminación de la tuberculosis como problema de salud pública. Situación de Chile en el año 2008. Rev Chil Enf Respir 2009; 24: 117-26.
4. FARGA V. La conquista de la tuberculosis. Rev Chil Enf Respir 2004 20:101-8.
5. WORLD HEALTH ORGANIZATION. Global Tuberculosis Control. WHO Report 2009.WHO/HTM/ TB/2009.411.
6. DORMAN S E. New diagnostic tests for tuberculosis: Bench, bedside, and beyond. Clin Infect Dis 2010; (50 Suppl 3): 17S-77S.
7. MA Z, LIENHARDT C, MCILLERON H, NUNN A J, WANG X. Global Tuberculosis drug development pipeline: the need and the reality. Lancet 2010; 375: 2100-9.
8. Centers of Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium Tuberculosis infection. MMWR 2010; 59 (RR-5): 1-26.
9. KAUFMANN S H, HUSSEY G, LAMBERT P H. New vaccines for tuberculosis. Lancet 2010; 375: 2110-19.
10. SWAMINATHAN S, PADMAPRIYADARSINI C, NARENDRAN G. HIV-associated tuberculosis. Clinical update. Cl Infect Dis 2010; 50: 1377-86.
11. CAMINERO J A. Multidrug-resistant tuberculosis: Epidemiology, risk factors and case-finding. Intl J Tuberc Lung Dis 2010; 14: 382-90.